Hasta la próxima

Auto reproducción

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

1 vistas • 07/14/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción